• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Organics Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92885.0
  • ISIN : INE0PE401018
43.70 2 (4.92%)
  • As on 27 Jul 2025 (EOD)

  • Today’s Low

    40.50

  • Today’s High

    43.70

  • Open

    43.60

  • Perv Close

    41.65

  • 52W Low

    19.60

  • 52W High

    100.00

Key Indicators

  • P/E(TTM)

    15.61

  • Mar.Cap (₹Cr.)

    51.13

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.76

  • Debt-Equity Ratio

    4.92

  • AGM Date

    25-Jul-2025

  • EPS

    2.80

  • P/E Ratio

    15.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    51.13

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.70

  • BV (₹)

    24.80

  • Sales( ₹ in Cr.)

    37.09

  • NP (in Cr.)

    3.27

  • NP Var(%)

    36.0

  • Div%

    0.0

  • CPS (₹)

    3.40

  • EPS (₹)

    2.80

  • Traded Value (₹ in Lakhs)

    51.13

  • 52 Week High

    100.00

  • 52 Week Low

    19.60

  • Price BSE

    0.0

  • Price NSE

    44.00

  • Market Capital( in Cr.)

    51.13

  • P/C Ratio

    12.80

  • P/E Ratio

    15.70

  • Price Vs.BV

    2.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 25.27 22.15 20.98 25.05 31.49 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 25.27 22.15 20.98 25.05 31.49 -
Other Income 0.02 0.82 0.21 0.01 0.09 -
Stock Adjustments 1.47 0.60 0.71 -0.55 0.19 -
Total Income 26.76 23.57 21.90 24.51 31.77 -
EXPENDITURE :            
Raw Materials 10.64 10.56 14.12 15.31 15.91 -
Power and Fuel Cost 0.97 0.82 0.72 0.91 1.20 -
Employee Cost 3.02 2.87 2.49 2.33 2.58 -
Other Manufacturing Expenses 5.69 5.06 1.56 2.05 8.84 -
Selling and Administration Expenses 1.41 1.47 1.47 1.80 1.59 -
Miscellaneous Expenses 0.26 0.10 0.14 0.47 0.20 -
Employee Benefit Expenses 3.02 2.87 2.49 2.33 2.58 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 22.01 20.88 20.49 22.86 30.33 -
Operating Profit 4.76 2.68 1.41 1.65 1.44 -
Interest 0.65 0.61 0.47 0.48 0.46 -
Gross Profit 4.11 2.07 0.94 1.17 0.98 -
Depreciation 0.72 0.71 0.68 0.68 0.77 -
Profit Before Tax 3.39 1.36 0.26 0.49 0.21 -
Current Tax 0.96 0.34 0.10 0.12 0.04 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.02 0.05 0.06 0.08 0.06 -
Reported Net Profit 2.40 0.97 0.09 0.30 0.10 -
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -
Adjusted Net Profit 2.40 0.97 0.09 0.30 0.10 -
Adjustment below Net Profit 0.00 0.00 0.00 0.06 0.01 -
P & L Balance brought forward 2.07 1.10 0.55 0.19 0.09 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 4.47 2.07 0.64 0.55 0.19 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 2.80 1.62 0.15 0.50 0.17 -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 17.66 14.97 12.60 12.45 11.85 -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    59.73%

  • Public Share Holding

    40.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,987,900 59.73 6,987,900 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,987,900 59.73 6,987,900 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,000 0.07 8,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,000 0.10 12,000 1
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 432,000 3.69 432,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 452,000 3.86 452,000 3
2] Non Institution
Bodies Corporate 318,000 2.72 318,000 14
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 268,000 2.29 268,000 15
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 306,000 2.62 306,000 21
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,514,000 12.94 1,514,000 18
Individuals holding nominal share capital up to Rs. 1 lakh 1,854,100 15.85 1,854,100 384
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,260,100 36.41 4,260,100 452
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,700,000 100.00 11,700,000 460

Company Background

Medicamen Organics LtdPharmaceuticals - Indian - Formulations

  • Medicamen Organics Ltd
  • BSE Code : 92885.0
  • ISIN : INE0PE401018

  • Incorporation Year

    1995

  • Registered Office

    10 Community Centre No 2
    Ashok Vihar Phase II, New Delhi,
    Delhi-110052

  • Telephone

    +91 98182 22845

  • FAX

  • Chairman

    B K Gupta

  • Managing Director

    B K Gupta

  • Company Secretary

    Varsha Bansal

  • Auditor

    N C Raj & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Medicamen Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Organ. 43.70 25.29 25.27 15.61 16.44
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10